Skip to content
Disclosery

ORBIMED ADVISORS LLC: EYPT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on EYPT, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 1,069,147 EYPT shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,069,147 shares
    Change vs previous 13F 0 shares

    0.29% of the 13F portfolio, value $15,288,802.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,069,147 shares
    Change vs previous 13F -1,399,167 shares

    0.3% of the 13F portfolio, value $13,781,305.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,468,314 shares
    Change vs previous 13F +672,314 shares

    0.92% of the 13F portfolio, value $45,096,097.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,796,000 shares
    Change vs previous 13F not available

    0.61% of the 13F portfolio, value $25,575,040.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).